Page last updated: 2024-10-16

gamma-aminobutyric acid and Neuroectodermal Tumors, Primitive

gamma-aminobutyric acid has been researched along with Neuroectodermal Tumors, Primitive in 1 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Neuroectodermal Tumors, Primitive: A group of malignant tumors of the nervous system that feature primitive cells with elements of neuronal and/or glial differentiation. Use of this term is limited by some authors to central nervous system tumors and others include neoplasms of similar origin which arise extracranially (i.e., NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL). This term is also occasionally used as a synonym for MEDULLOBLASTOMA. In general, these tumors arise in the first decade of life and tend to be highly malignant. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2059)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Florian, CL1
Pietsch, T1
Noble, M1
Williams, SR1

Other Studies

1 other study available for gamma-aminobutyric acid and Neuroectodermal Tumors, Primitive

ArticleYear
Metabolic studies of human primitive neuroectodermal tumour cells by proton nuclear magnetic resonance spectroscopy.
    British journal of cancer, 1997, Volume: 75, Issue:7

    Topics: Aspartic Acid; Cerebellar Neoplasms; Cerebellum; Chromatography, High Pressure Liquid; gamma-Aminobu

1997